FDA's COSMETIC HOTLINE EXPECTED TO GENERATE SOME OTC ADVERSE REPORTS
This article was originally published in The Tan Sheet
Executive Summary
FDA's COSMETIC HOTLINE EXPECTED TO GENERATE SOME OTC ADVERSE REPORTS, according to agency staffers. Intended to allow consumers to report adverse cosmetic experiences directly to the agency, the Cosmetic Adverse Reaction Hotline likely will receive some reports of adverse reactions with over-the-counter drugs because many consumers may not be able to determine what is considered a cosmetic and what is considered an OTC drug, FDA said. In addition, the hotline will cover OTCs such as dentifrices and suntan products.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning